InflammamiR-146a and -155 Plasma Levels are Associated with Clinical Efficacy of Risankizumab Treatment in Psoriatic Patients: Pilot Study

• Principais autores: Federico Diotallevi (Autor), Giulia Matacchione (Autor), Giovanni Marco d'Agostino (Autor), Helena Gioacchini (Autor), Anna Campanati (Autor), Jacopo Sabbatinelli (Autor), Fabiola Olivieri (Autor), Annamaria Offidani (Autor)
• Formato: Livro
• Publicado em: Adis, Springer Healthcare, 2023-05-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Introduction The key role of microRNAs (miRNAs) in the pathogenesis of psoriasis has been extensively discussed in the literature. Increasing evidence suggests that the analysis of miRNA levels may constitute an innovative approach for exploring the clinical efficacy of anti-inflammatory th...